1.Chihara A, Tanaka A, Morimoto T, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Ueda S, Node K. Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: A secondary analysis of the REASON trial. Cardiovasc Diabetol 2019;18:158 pubmed
2.Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama J-r, Lei X-F, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M. Toll-like receptor 9 plays a pivotal role in angiotensin II-induced atherosclerosis. J Am Heart Assoc 2019;8:e010860. pubmed
3.Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep 2019;9:2813. pubmed
4.Hokama N, Shirakura T, Sunagawa S, Morishima S, Nakachi S, Nishi Y, Murayama Y, Matsui C, Hase N, Tamura M, Okamoto S, Shimabukuro M, Nakamura K, Masuzaki H. A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly-sensitive assay. Hematol Oncol 2019;37:527-530 pubmed
5.Kudo A. Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. Fast eating is a strong risk factor for new-onset diabetes among the Japanese general population. Sci Rep 2019;9:8210. pubmed
6.Millman J, Okamoto S, Kimura A, Uema T, Higa M, Yonamine M, Namba T, Ogata E, Yamazaki S, Shimabukuro M, Tsutsui M, Matsushita M, Ikematsu S, Masuzaki H. Metabolically and immunologically beneficial impact of extra virgin olive and flaxseed oils on composition of gut microbiota in mice. Eur J Nutr 2019;59:2411-2425 pubmed
7.Morimoto T, Sakuma M, Tokushige A, Natsuaki M, Asahi T, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial. Sci Rep 2019;9:8537. pubmed
8.Nakajima A, Tanaka K, Saito H, Iwasaki T, Oda A, Kanno M, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Blood pressure control in chronic kidney disease according to underlying renal disease: The Fukushima CKD Cohort. Clin Exp Nephrol 2019;24:427-43 pubmed
9.Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.Rivaroxaban, a specific Fxa inhibitor, improved endotheliumdependent relaxation of aortic segments in diabetic mice. Sci Rep2019:9;11206 pubmed
10.Sugasawa N, Katagi A, Kurobe H, Nakayama T, Nishio C, Takumi H, Higashiguchi F, Aihara KI, Shimabukuro M, Sata M, Kitagawa T. Inhibition of atherosclerotic plaque development by oral administration of alpha-glucosyl hesperidin and water-dispersible hesperetin in apolipoprotein E knockout mice. J Am Coll Nutr 2019;38:15-22. pubmed
11.Sunagawa S, Shirakura T, Hokama N, Kozuka C, Yanamine M, Namba T, Morishima S, Nakachi S, Nishi Y, Ikema T, Okamoto S, Matsui C, Hase N, Tamura M, Shimabukuro M, Masuzaki H. Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in Japanese patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study. J Diabetes Investig 2019;10:94-103. pubmed
12.Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima K, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K. Effect of empagliflozin on endothelial function in patients with type 2 diabetes and cardiovascular diseases: results from the multicenter, randomized, placebo-controlled, double-blind EMBLEM trial. Diabetes Care 2019;42:e159-e161 pubmed
13.Yagi S, Kondo T, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata I, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M. Association of decreased docosahexaenoic acid level after statin therapy and low eicosapentaenoic acid level with in-stent restenosis in patients with acute coronary syndrome. J Atheroscler Thromb 2019;26:272-281. pubmed
14.Yamaguchi S, Abe M, Arasaki O, Shimabukuro M, Ueda S. A prognostic impact of concentric left ventricular structure observed by transthoracic echocardiography in patients with acute decompensated heart failure: a retrospective study. Int J Cardiol 2019;287:73-80. pubmed
15.Yamaguchi S, Abe M, Arasaki O, Shimabukuro M. The incremental prognostic value of platelet count in patients with acute heart failure: a retrospective observational study. Circ J 2019;83:576-583. pubmed
16.Yamaguch S, Shimabukuro M, Abe M, Arakaki T, Arasaki O, Ueda S. Comparison of the prognostic values of three calculation methods for echocardiographic relative wall thickness in acute decompensated heart failure. Cardiovasc Ultrasound 2019;17:30. pubmed
英文総説
・Masuzaki H, Kozuka C, Okamoto S, Yonamine M, Tanaka H, Shimabukuro M. Brown rice-specific gamma-oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity disease in humans. J Diabetes Invest 2019;10:18-25. pubmed
・Shimabukuro M. SIRT1 and gender differences in atherosclerotic cardiovascular disease. J Atheroscler Thromb in press
ESC Congress 2019 together with World Congress of Cardiology, Paris, France, 31 August - 04 September 2019
Maimaituxun G, Kusunose K, Fukuda D, Yagi S, Torii Y, Hirata Y, Nishio S, Yamada N, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M. Impact of epicardial adipose tissue on global longitudinal strain: a study in patients with normal left ventricular ejection fraction
Maimaituxun G, Fukuda D, Yagi S, Takao S, Hirata Y, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M: Adipose tissue surrounding the kidney and its impact on coronary artery disease
The 2nd Surabaya International Health Conference (SIHC 2019), Surabaya, Indonesia, 13-14 July, 2019
Shimabukuro M. Obesiy, obesity disease & ectopic fat deposition New critical paradigmin life-style related medicine
The 7th International Conference on Food Factors (ICoFF2019), Kobe, 01-05 December 2019
Shimabukuro M. Ectopic fat depots and cardiometabolic disease: how food factors are linked?
Anagliptin and Sitagliptin on LDL- cholesterol in Type 2 Diabetic Patients with Dys- lipidemia and Cardiovascular Risk Results from Reason Trial
>Maimaituxun G, Fukuda D, Yagi S, Hirata Y, Iwase T, Matsuura t, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M. Epicardial Adipose Tissue Thickness is Gender Specific and Linked to Coronary Atherosclerosis in Men.
Yamaguchi S, Abe M, Arakaki T, Arasaki O, Shimabukuro M, Ueda S. The Prognostic Impact of a Concentric Left Ventricular Structure Evaluated by Transthoracic Echocardiography in Patients with Acute Decom- pensated Heart Failure
Pham TP, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M. Rivaroxaban, A Direct Inhibitor of FXa, Attenu- ated Diabetes-induced Endothelial Dysfunction by Inhibiting FXa-protease Activated Receptor 2 Signaling.
Maimaituxun G, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M, Shimabukuro M. Kidney fat and its impact on coronary artery disease
Maimaituxun G, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M, Shimabukuro M. Peri-renal fat volume is negatively associated with the adiponectin expression in human
Maimaituxun G, Fukuda D, Yagi S, Hirata Y, Iwase T, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M, Shimabukuro M. A gender-specific link between epicardial adipose tissue thickness and coronary atherosclerosis
Maimaituxun G, Kusunose K, Yamada H, Fukuda D, Yagi S, Hirata Y, Iwase T, Soeki T, Sata M, Shimabukuro M. Impact of epicardial adipose tissue thickness on left ventricular diastolic dysfunction in human
Maimaituxun G, Fukuda D, Yagi S, Iwase T, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M. Type 2diabetes, but not epicardial adipose tissue thickness is a predictor forcoronary artery disease in women
第19回日本日本抗加齢医学会総会(横浜:2019年6月14日-16日)
Maimaituxun G, Fukuda D, Yagi S, Iwase T, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M. Gender specific impact of epicardial adipose tissue thickness on coronary artery disease.